格隆汇7月25日丨上海医药(601607.SH)公布,公司拟以自有资金约人民币1.43亿元(以最终国资备案价格为准)收购上海实业东滩投资开发(集团)有限公司(简称“上实东滩”)持有的上海上实集团财务有限公司(简称“财务公司”或“标的公司”)10%股权。本次交易完成后,公司持有财务公司的股权比例由30%增加至40%,不会导致公司合并报表范围发生变更。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.